Company Matinas BioPharma Holdings Inc Other OTC
Equities
US5768101058
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
09/05 | Transcript : Matinas BioPharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Matinas BioPharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Pharmaceutical Products
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -65.62% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 3 | 100.0 % | 1 | 100.0 % | -65.62% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerome Jabbour
FOU | Founder | 50 | 01/13/01 |
Keith Kucinski
DFI | Director of Finance/CFO | 55 | 03/19/03 |
Hui Liu
CTO | Chief Tech/Sci/R&D Officer | 56 | 01/20/01 |
James Ferguson
CTO | Chief Tech/Sci/R&D Officer | 70 | 25/19/25 |
Corporate Officer/Principal | 56 | 15/18/15 | |
Thomas Hoover
PRN | Corporate Officer/Principal | 55 | 06/21/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
FOU | Founder | 91 | 01/13/01 |
Natasha Giordano
BRD | Director/Board Member | 62 | 14/20/14 |
Eric Ende
CHM | Chairman | 55 | 03/17/03 |
James Scibetta
BRD | Director/Board Member | 59 | 01/13/01 |
Matthew Wikler
BRD | Director/Board Member | 74 | 01/18/01 |
Kathryn Corzo
BRD | Director/Board Member | 63 | 01/21/01 |
Jerome Jabbour
FOU | Founder | 50 | 01/13/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 250,816,164 | 244,482,252 ( 97.47 %) | 0 | 97.47 % |
Company contact information
Matinas BioPharma Holdings, Inc.
1545 Route 206 South Suite 302
07921-9999, Bedminster
+908 484 8805
http://www.matinasbiopharma.comSector
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- MTNB Stock
- Stock
- Company Matinas BioPharma Holdings Inc